Schwartz R H, Paul W E
J Exp Med. 1976 Mar 1;143(3):529-40. doi: 10.1084/jem.143.3.529.
The recent introduction of a reliable, T-lymphocyte proliferation assay, which utilizes thioglycollate-induced, nylon wool column-passed, peritoneal exudate lymphocytes from immune mice (PETLES), allowed us to investigate the genetic control of murine immune responses at the T-lymphocyte level. Examination of the blast cells generated in this population 5 days after stimulation with antigen, revealed that 85% of the cells bore the Thy 1 antigen on their surface, whereas only 5% bore immunoglobulin. Thus, the assay can be considered to measure almost exclusively T-lymphocyte function. This assay was used to examine the T-lymphocyte proliferative responses to seven different antigens: poly(Glu60Ala30Tyr10), poly(Glu58Lys38Tyr4), poly-(Tyr,Glu)-poly-D,L-Ala--poly-Lys, poly-(Phe,Glu)-poly-D,L-Ala--poly-Lys, staphylococcal nuclease, lactate dehydrogenase H4, and the BALB/c IgA myeloma protein, TEPC-15. PETLES from a large number of different inbred mouse strains, including H-2 congenic resistant lines and H-2 recombinants, were studied. The strains could be classified as high responders, low responders, or nonresponders to a particular antigen as judged by the magnitude of the T-lymphocyte proliferative response. In every case but one this classification corresponded to the responder status given the strain based on its ability to mount an in vivo antibody response to the same antigen. For two of the antigens, poly-(Tyr,Glu)-poly-D,L-Ala--poly-Lys and TEPC-15, the immune response genes controlling the T-lymphocyte proliferative response were mapped to the K region or I-A subregion of the major histocompatibility complex, as had previously been shown for the control of the antibody responses to these antigens. This tight linkage of the two phenotypic responses very strongly suggests that the same immune response gene controls the expression of both the proliferative and antibody responses. Since there is essentially no contribution from B lymphocytes in the T-lymphocyte proliferation assay, it seems reasonable to conclude that none of the seven immune response genes studied are expressed solely in B lymphocytes.
最近引入了一种可靠的T淋巴细胞增殖试验,该试验利用来自免疫小鼠的经巯基乙酸盐诱导、通过尼龙毛柱的腹腔渗出淋巴细胞(PETLES),使我们能够在T淋巴细胞水平上研究小鼠免疫反应的遗传控制。在用抗原刺激5天后,对该群体中产生的母细胞进行检查,发现85%的细胞表面带有Thy 1抗原,而只有5%的细胞带有免疫球蛋白。因此,该试验几乎可以被认为专门用于测量T淋巴细胞功能。该试验用于检测对七种不同抗原的T淋巴细胞增殖反应:聚(Glu60Ala30Tyr10)、聚(Glu58Lys38Tyr4)、聚(Tyr,Glu)-聚-D,L-丙氨酸-聚-L-赖氨酸、聚(Phe,Glu)-聚-D,L-丙氨酸-聚-L-赖氨酸、葡萄球菌核酸酶、乳酸脱氢酶H4以及BALB/c IgA骨髓瘤蛋白TEPC-15。研究了来自大量不同近交系小鼠的PETLES,包括H-2同源抗性系和H-2重组体。根据T淋巴细胞增殖反应的强度,这些品系可被分类为对特定抗原的高反应者、低反应者或无反应者。在除一种情况外的每种情况下,这种分类都与根据品系对同一抗原产生体内抗体反应的能力所确定的反应者状态相对应。对于其中两种抗原,聚(Tyr,Glu)-聚-D,L-丙氨酸-聚-L-赖氨酸和TEPC-15,控制T淋巴细胞增殖反应的免疫反应基因被定位到主要组织相容性复合体的K区域或I-A亚区域,正如先前对这些抗原的抗体反应控制所显示的那样。这两种表型反应的紧密连锁非常强烈地表明,相同的免疫反应基因控制增殖反应和抗体反应的表达。由于在T淋巴细胞增殖试验中基本上没有B淋巴细胞的贡献,因此可以合理地得出结论,所研究的七个免疫反应基因中没有一个仅在B淋巴细胞中表达。